Access this insightful resource to learn more about AOF
T cell medium formulations. We explore results from a detailed evaluation of the offerings by top industry suppliers, with a look at key performance capabilities using cells from both healthy donors and diseased donors. The criteria for comparison included transduction efficiency, transduced early memory phenotype, cell expansion, and viability.
You are currently subscribed as newsletter@newslettercollector.com.
